newsfilter
← Latest News
GlobeNewswire·

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

  • Beyond Air, Inc. (NASDAQ: XAIR) announced that Chairman & CEO Steve Lisi will attend two upcoming investor conferences.
  • Lisi will participate in the 13th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT from February 9 to 11, 2026.
  • Lisi will also present at the Noble Capital Markets Emerging Growth Virtual Equity Conference from February 4 to 5, 2026.
  • A live webcast of Lisi's corporate presentation is scheduled for Thursday, February 5, 2026, at 2:00 pm ET.
  • Beyond Air is a commercial-stage medical device & biopharmaceutical company focused on using nitric oxide to treat respiratory illnesses, neurological disorders, & solid tumors.
  • The company holds FDA approval & CE Mark for its LungFit PH system, which treats hypoxic respiratory failure in term & near-term neonates.
  • Beyond Air is advancing clinical trials for other LungFit systems to treat severe lung infections, including viral community-acquired pneumonia & nontuberculous mycobacteria.
  • An affiliate, Beyond Cancer, Ltd., is investigating ultra-high concentrations of nitric oxide to target solid tumors in pre-clinical settings.
  • Investors may schedule one-on-one meetings by contacting their respective bank representatives.